Caught in Political Crosshairs

AP Photo/Lubbock Avalanche-Journal, Jim Watkins  Thomas Butler It's open season on life scientists. The Federal Bureau of Investigations (FBI) is doggedly determined to prove that Thomas Butler, a researcher and international plague authority at Texas Tech University, is a biocriminal. Ebola investigator Steven J. Hatfill, formerly with the United States Army Medical Research Institute for Infectious Disease (USAMRIID), may never recover from the suspicion cast by the FBI's constant surv

Written byJohn Dudley Miller
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

It's open season on life scientists. The Federal Bureau of Investigations (FBI) is doggedly determined to prove that Thomas Butler, a researcher and international plague authority at Texas Tech University, is a biocriminal. Ebola investigator Steven J. Hatfill, formerly with the United States Army Medical Research Institute for Infectious Disease (USAMRIID), may never recover from the suspicion cast by the FBI's constant surveillance after he was named a "person of interest" in its anthrax letters case. In Britain, microbiologist David Kelly committed suicide after Tony Blair's press officer exposed Kelly as a possible source for a BBC story asserting that the government exaggerated Iraq's weapons capability to build its case for war.

Together, these cases threaten to sour relationships between scientists and their governments, prompting researchers to avoid biodefense work just when the governments need them most.

In August, the presidents of the National Academy of Sciences and the Institute ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies